119 related articles for article (PubMed ID: 11229304)
1. [Palpable mantel cell lymphoma in the breast].
Boullanger N; Renou P; Dugay J; Boyer J; de Yberlucea LR; Combe M; Coulon MA
Presse Med; 2001 Feb; 30(4):163-5. PubMed ID: 11229304
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma in the ocular adnexal region.
Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
[TBL] [Abstract][Full Text] [Related]
3. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
5. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma presenting as a breast mass.
Windrum P; Morris TC; Catherwood MA; Alexander HD; McManus DT; Markey GM
J Clin Pathol; 2001 Nov; 54(11):883-6. PubMed ID: 11684727
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
[TBL] [Abstract][Full Text] [Related]
8. [Mantle-cell lymphoma of the ocular adnexa: a case report].
de Albuquerque AP; Aguni JS; Correia RJ; Vegini F; de Souza AD
Arq Bras Oftalmol; 2006; 69(3):421-5. PubMed ID: 16936971
[TBL] [Abstract][Full Text] [Related]
9. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
11. Current treatment approaches for mantle-cell lymphoma.
Witzig TE
J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
[TBL] [Abstract][Full Text] [Related]
12. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
13. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
14. Current treatment standards and emerging strategies in mantle cell lymphoma.
Dreyling M; Hiddemann W;
Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
[TBL] [Abstract][Full Text] [Related]
15. Follicular conjunctivitis caused by a mantle cell lymphoma.
Amstutz CA; Michel S; Thiel MA
Klin Monbl Augenheilkd; 2004 May; 221(5):398-400. PubMed ID: 15162290
[TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
17. From the archives of MD Anderson Cancer Center: Untreated leukemic non-nodal mantle cell lymphoma with relapse as pleomorphic variant mantle cell lymphoma 21 years later.
Fang H; Medeiros LJ; Tang Z; Wang W; Ok CY; Patel KP; Khoury JD; Thakral B
Ann Diagn Pathol; 2021 Feb; 50():151649. PubMed ID: 33189964
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
20. Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.
Lefrère F; Delmer A; Suzan F; Levy V; Belanger C; Djabarri M; Arnulf B; Damaj G; Maillard N; Ribrag V; Janvier M; Sebban C; Casasnovas RO; Bouabdallah R; Dreyfus F; Verkarre V; Delabesse E; Valensi F; McIntyre E; Brousse N; Varet B; Hermine O
Leukemia; 2002 Apr; 16(4):587-93. PubMed ID: 11960337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]